# SPRING MILL PHARMA INCORPORATED: Discovery of novel PBP-targeting chemical warheads to address multidrug-resistant Pseudomonas aeruginosa

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | SPRING MILL PHARMA INCORPORATED |
| Location | MALVERN, PA |
| Project | Discovery of novel PBP-targeting chemical warheads to address multidrug-resistant Pseudomonas aeruginosa |
| Project number | 1R43AI197818-01 |
| Mechanism | R43 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $300,000 |
| Awarded | 2026-09-11 |
| Project period | 2026-08-11 to 2028-07-31 |
| UEI | UWZNAK5HJLN7 |

## Why this score
- Award of $300,000.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11315103). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.